Allergic 0 8 0 8 O
reactions 9 18 9 18 O
or 19 21 19 21 O
acute 22 27 22 27 O
hypersensitivity 28 44 28 44 O
reaction 45 53 45 53 O
attributed 54 64 54 64 O
to 65 67 65 67 O
antibody 68 76 68 76 B-allergy_name
treatments 77 87 77 87 I-allergy_name

At 0 2 88 90 O
least 3 8 91 96 O
1 9 10 97 98 B-lower_bound
measurable 11 21 99 109 O
lesion 22 28 110 116 O

Eastern 0 7 117 124 B-clinical_variable
Cooperative 8 19 125 136 I-clinical_variable
Oncology 20 28 137 145 I-clinical_variable
Group 29 34 146 151 I-clinical_variable
( 35 36 152 153 I-clinical_variable
ECOG 36 40 153 157 I-clinical_variable
) 40 41 157 158 I-clinical_variable
performance 42 53 159 170 I-clinical_variable
status 54 60 171 177 I-clinical_variable
≤1 61 63 178 180 O

Immunosuppressive 0 17 181 198 B-clinical_variable
corticosteroid 18 32 199 213 I-clinical_variable
doses 33 38 214 219 I-clinical_variable
( 39 40 220 221 O
> 40 41 221 222 O
10 41 43 222 224 B-lower_bound
mg 44 46 225 227 I-lower_bound
prednisone 47 57 228 238 O
daily 58 63 239 244 O
or 64 66 245 247 O
equivalent 67 77 248 258 O
) 77 78 258 259 O
within 79 85 260 266 O
4 86 87 267 268 B-upper_bound
weeks 88 93 269 274 I-upper_bound
prior 94 99 275 280 I-upper_bound
to 100 102 281 283 O
the 103 106 284 287 O
first 107 112 288 293 O
dose 113 117 294 298 O
of 118 120 299 301 O
cemiplimab 121 131 302 312 B-treatment

Infection 0 9 313 322 O
with 10 14 323 327 O
human 15 20 328 333 B-chronic_disease
immunodeficiency 21 37 334 350 I-chronic_disease
virus 38 43 351 356 I-chronic_disease
( 44 45 357 358 I-chronic_disease
HIV 45 48 358 361 I-chronic_disease
) 48 49 361 362 I-chronic_disease
and/or 50 56 363 369 O
chronic 57 64 370 377 B-chronic_disease
/ 64 65 377 378 I-chronic_disease
active 65 71 378 384 I-chronic_disease
infection 72 81 385 394 I-chronic_disease
with 82 86 395 399 O
hepatitis 87 96 400 409 B-chronic_disease
B 97 98 410 411 I-chronic_disease
virus 99 104 412 417 I-chronic_disease
or 105 107 418 420 O
hepatitis 108 117 421 430 B-chronic_disease
C 118 119 431 432 I-chronic_disease
virus 120 125 433 438 I-chronic_disease

Ongoing 0 7 439 446 O
or 8 10 447 449 O
recent 11 17 450 456 O
( 18 19 457 458 O
within 19 25 458 464 O
5 26 27 465 466 B-upper_bound
years 28 33 467 472 I-upper_bound
) 33 34 472 473 O
evidence 35 43 474 482 O
of 44 46 483 485 O
significant 47 58 486 497 O
autoimmune 59 69 498 508 B-chronic_disease
disease 70 77 509 516 I-chronic_disease
that 78 82 517 521 O
required 83 91 522 530 O
treatment 92 101 531 540 B-treatment
with 102 106 541 545 O
systemic 107 115 546 554 B-treatment
immunosuppressive 116 133 555 572 I-treatment
treatments 134 144 573 583 B-treatment
, 144 145 583 584 O
which 146 151 585 590 O
may 152 155 591 594 O
suggest 156 163 595 602 O
risk 164 168 603 607 O
for 169 172 608 611 O
immune 173 179 612 618 B-chronic_disease
- 179 180 618 619 I-chronic_disease
related 180 187 619 626 I-chronic_disease
adverse 188 195 627 634 I-chronic_disease
events 196 202 635 641 I-chronic_disease

Patients 0 8 642 650 O
must 9 13 651 655 O
consent 14 21 656 663 O
to 22 24 664 666 O
undergo 25 32 667 674 O
biopsies 33 41 675 683 B-treatment
of 42 44 684 686 O
CSCC 45 49 687 691 B-cancer
lesions 50 57 692 699 I-cancer
( 58 59 700 701 O
Groups 59 65 701 707 O
2 66 67 708 709 O
and 68 71 710 713 O
4 72 73 714 715 O
only 74 78 716 720 O
) 78 79 720 721 O

Patients 0 8 722 730 O
with 9 13 731 735 O
a 14 15 736 737 O
history 16 23 738 745 O
of 24 26 746 748 O
solid 27 32 749 754 B-treatment
organ 33 38 755 760 I-treatment
transplant 39 49 761 771 I-treatment

Prior 0 5 772 777 B-treatment
treatment 6 15 778 787 I-treatment
with 16 20 788 792 I-treatment
other 21 26 793 798 I-treatment
immune 27 33 799 805 I-treatment
- 33 34 805 806 I-treatment
modulating 34 44 806 816 I-treatment
agents 45 51 817 823 I-treatment
within 52 58 824 830 O
fewer 59 64 831 836 O
than 65 69 837 841 O
4 70 71 842 843 B-upper_bound
weeks 72 77 844 849 I-upper_bound
prior 78 83 850 855 I-upper_bound
to 84 86 856 858 O
the 87 90 859 862 O
first 91 96 863 868 O
dose 97 101 869 873 O
of 102 104 874 876 O
cemiplimab 105 115 877 887 B-treatment
, 115 116 887 888 O
or 117 119 889 891 O
associated 120 130 892 902 O
with 131 135 903 907 O
immune 136 142 908 914 O
- 142 143 914 915 O
mediated 143 151 915 923 O
adverse 152 159 924 931 O
events 160 166 932 938 O
that 167 171 939 943 O
were 172 176 944 948 O
≥ 177 178 949 950 O
grade 179 184 951 956 B-lower_bound
1 185 186 957 958 I-lower_bound
within 187 193 959 965 O
90 194 196 966 968 B-upper_bound
days 197 201 969 973 I-upper_bound
prior 202 207 974 979 I-upper_bound
to 208 210 980 982 O
the 211 214 983 986 O
first 215 220 987 992 O
dose 221 225 993 997 O
of 226 228 998 1000 O
cemiplimab 229 239 1001 1011 O
, 239 240 1011 1012 O
or 241 243 1013 1015 O
associated 244 254 1016 1026 O
with 255 259 1027 1031 O
toxicity 260 268 1032 1040 O
that 269 273 1041 1045 O
resulted 274 282 1046 1054 O
in 283 285 1055 1057 O
discontinuation 286 301 1058 1073 O
of 302 304 1074 1076 O
the 305 308 1077 1080 O
immune 309 315 1081 1087 O
- 315 316 1087 1088 O
modulating 316 326 1088 1098 O
agent 327 332 1099 1104 O
. 332 333 1104 1105 O
Examples 334 342 1106 1114 O
of 343 345 1115 1117 O
immune 346 352 1118 1124 O
- 352 353 1124 1125 O
modulating 353 363 1125 1135 O
agents 364 370 1136 1142 O
include 371 378 1143 1150 O
therapeutic 379 390 1151 1162 B-treatment
vaccines 391 399 1163 1171 I-treatment
, 399 400 1171 1172 O
cytokine 401 409 1173 1181 B-treatment
treatments 410 420 1182 1192 I-treatment
, 420 421 1192 1193 O
or 422 424 1194 1196 O
agents 425 431 1197 1203 B-treatment
that 432 436 1204 1208 I-treatment
target 437 443 1209 1215 I-treatment
cytotoxic 444 453 1216 1225 I-treatment
T 454 455 1226 1227 I-treatment
- 455 456 1227 1228 I-treatment
lymphocyte 456 466 1228 1238 I-treatment
antigen 467 474 1239 1246 I-treatment
4 475 476 1247 1248 I-treatment
( 477 478 1249 1250 I-treatment
CTLA-4 478 484 1250 1256 I-treatment
) 484 485 1256 1257 I-treatment
, 485 486 1257 1258 I-treatment
4 487 488 1259 1260 I-treatment
- 488 489 1260 1261 I-treatment
1BB 489 492 1261 1264 I-treatment
( 493 494 1265 1266 I-treatment
CD137 494 499 1266 1271 I-treatment
) 499 500 1271 1272 I-treatment
, 500 501 1272 1273 I-treatment
or 502 504 1274 1276 I-treatment
OX-40 505 510 1277 1282 I-treatment

Untreated 0 9 1283 1292 O
brain 10 15 1293 1298 B-cancer
metastasis(es 16 29 1299 1312 I-cancer
) 29 30 1312 1313 I-cancer
that 31 35 1314 1318 O
may 36 39 1319 1322 O
be 40 42 1323 1325 O
considered 43 53 1326 1336 O
active 54 60 1337 1343 O

